Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Recurrent SARS-CoV-2 Mutations in Immunodeficient Patients

View ORCID ProfileSam AJ Wilkinson, Alex Richter, Anna Casey, Husam Osman, Jeremy D Mirza, Joanne Stockton, Josh Quick, Liz Ratcliffe, Natalie Sparks, Nicola Cumley, Radoslaw Poplawski, Sam Nicholls, Beatrix Kele, Kathryn Harris, The COVID-19 Genomics UK (COG-UK) consortium, Thomas P Peacock, Nicholas J Loman
doi: https://doi.org/10.1101/2022.03.02.22271697
Sam AJ Wilkinson
1Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, UK, B15 2TT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sam AJ Wilkinson
Alex Richter
2Institute of Immunology and Immunotherapy (III), College of Medical and Dental Sciences, University of Birmingham, UK, B15 2TT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Casey
1Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, UK, B15 2TT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Husam Osman
3Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, UK, B15 2TH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy D Mirza
1Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, UK, B15 2TT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanne Stockton
1Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, UK, B15 2TT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josh Quick
1Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, UK, B15 2TT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liz Ratcliffe
3Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, UK, B15 2TH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Sparks
1Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, UK, B15 2TT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicola Cumley
1Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, UK, B15 2TT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Radoslaw Poplawski
1Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, UK, B15 2TT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sam Nicholls
1Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, UK, B15 2TT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beatrix Kele
4Virology Department, NHS East and South East London Pathology Partnership, Royal London Hospital, Barts Health NHS Trust, UK, EC1A 7BE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn Harris
4Virology Department, NHS East and South East London Pathology Partnership, Royal London Hospital, Barts Health NHS Trust, UK, EC1A 7BE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas P Peacock
6Department of Infectious Disease, Imperial College London, London, UK, W2 1PG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: n.j.loman@bham.ac.uk
Nicholas J Loman
1Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, UK, B15 2TT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: n.j.loman@bham.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Long-term SARS-CoV-2 infections in immunodeficient patients are an important source of variation for the virus but are understudied. Many case studies have been published which describe one or a small number of long-term infected individuals but no study has combined these sequences into a cohesive dataset. This work aims to rectify this and study the genomics of this patient group through a combination of literature searches as well as identifying new case series directly from the COG-UK dataset. The spike gene receptor binding domain (RBD) and N-terminal domains (NTD) were identified as mutation hotspots. Numerous mutations associated with variants of concern were observed to emerge recurrently. Additionally a mutation in the envelope gene, - T30I was determined to be the most recurrent frequently occurring mutation arising in persistent infections. A high proportion of recurrent mutations in immunodeficient individuals are associated with ACE2 affinity, immune escape, or viral packaging optimisation.

There is an apparent selective pressure for mutations which aid intra-host transmission or persistence which are often different to mutations which aid inter-host transmission, although the fact that multiple recurrent de novo mutations are considered defining for variants of concern strongly indicates that this potential source of novel variants should not be discounted.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) [grant code: MC_PC_19027], and Genome Research Limited, operating as the Wellcome Sanger Institute.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The COG-UK study protocol was approved by the Public Health England Research Ethics Governance Group (reference: R&D NR0195). Authors only had access to anonymised data. No individual patient consent was required.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵5 https://www.cogconsortium.uk - Full list of consortium names and affiliations are in the appendix

Data Availability

All data included in the present work are available online or upon reasonable request to the producing author. The full details of the data are available within the supplement.

https://github.com/BioWilko/recurrent-sars-cov-2-mutations

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 02, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Recurrent SARS-CoV-2 Mutations in Immunodeficient Patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Recurrent SARS-CoV-2 Mutations in Immunodeficient Patients
Sam AJ Wilkinson, Alex Richter, Anna Casey, Husam Osman, Jeremy D Mirza, Joanne Stockton, Josh Quick, Liz Ratcliffe, Natalie Sparks, Nicola Cumley, Radoslaw Poplawski, Sam Nicholls, Beatrix Kele, Kathryn Harris, The COVID-19 Genomics UK (COG-UK) consortium, Thomas P Peacock, Nicholas J Loman
medRxiv 2022.03.02.22271697; doi: https://doi.org/10.1101/2022.03.02.22271697
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Recurrent SARS-CoV-2 Mutations in Immunodeficient Patients
Sam AJ Wilkinson, Alex Richter, Anna Casey, Husam Osman, Jeremy D Mirza, Joanne Stockton, Josh Quick, Liz Ratcliffe, Natalie Sparks, Nicola Cumley, Radoslaw Poplawski, Sam Nicholls, Beatrix Kele, Kathryn Harris, The COVID-19 Genomics UK (COG-UK) consortium, Thomas P Peacock, Nicholas J Loman
medRxiv 2022.03.02.22271697; doi: https://doi.org/10.1101/2022.03.02.22271697

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1097)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9773)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2313)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1562)
  • Health Policy (736)
  • Health Systems and Quality Improvement (604)
  • Hematology (238)
  • HIV/AIDS (504)
  • Infectious Diseases (except HIV/AIDS) (11650)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2144)
  • Nursing (134)
  • Nutrition (337)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1180)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (147)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2182)
  • Public and Global Health (4663)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)